{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:32:37Z","timestamp":1782538357304,"version":"3.54.5"},"reference-count":211,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,11,8]]},"abstract":"<jats:p>Alzheimer\u2019s disease (AD) represents a global health challenge, with an estimated 55 million people suffering from the non-curable disease across the world. While amyloid-\u03b2 plaques and tau neurofibrillary tangles in the brain define AD proteinopathy, it has become evident that diverse coding and non-coding regions of the genome may significantly contribute to AD neurodegeneration. The diversity of factors associated with AD pathogenesis, coupled with age-associated damage, suggests that a series of triggering events may be required to initiate AD. Since somatic mutations accumulate with aging, and aging is a major risk factor for AD, there is a great potential for somatic mutational events to drive disease. Indeed, recent data from the Gozes team\/laboratories as well as other leading laboratories correlated the accumulation of somatic brain mutations with the progression of tauopathy. In this review, we lay the current perspectives on the principal genetic factors associated with AD and the potential causes, highlighting the contribution of somatic mutations to the pathogenesis of late onset Alzheimer\u2019s disease. The roles that artificial intelligence and big data can play in accelerating the progress of causal somatic mutation markers\/biomarkers identification, and the associated drug discovery\/repurposing, have been highlighted for future AD and other neurodegenerations, with the aim to bring hope for the vulnerable aging population.<\/jats:p>","DOI":"10.3233\/jad-220643","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T14:20:41Z","timestamp":1663683641000},"page":"475-493","source":"Crossref","is-referenced-by-count":17,"title":["Somatic Mutations and Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"90","author":[{"given":"Jocelyn","family":"Downey","sequence":"first","affiliation":[{"name":"Department of Electrical and Electronic Engineering, The University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline C.K.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Electrical and Electronic Engineering, The University of Hong Kong, Hong Kong, China"},{"name":"Department of Computer Science and Technology, University of Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor O.K.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Electrical and Electronic Engineering, The University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illana","family":"Gozes","sequence":"additional","affiliation":[{"name":"The Elton Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Adams Super Center for Brain Studies and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220643_ref1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41380-019-0563-5","article-title":"Discovery of autism\/intellectual disability somatic mutations in Alzheimer\u2019s brains: Mutated ADNP cytoskeletal impairments and repair as a case study","volume":"26","author":"Ivashko-Pachima","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-220643_ref2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/alz.12211","article-title":"Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer\u2019s disease: Implications for disease etiology","volume":"17","author":"Soheili-Nezhad","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220643_ref3","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1038\/s41467-019-11000-7","article-title":"Brain somatic mutations observed in Alzheimer\u2019s disease associated with aging and dysregulation of tau phosphorylation","volume":"10","author":"Park","year":"2019","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-220643_ref4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1126\/science.aao4426","article-title":"Aging and neurodegeneration are associated with increased mutations in single human neurons","volume":"359","author":"Lodato","year":"2018","journal-title":"Science"},{"key":"10.3233\/JAD-220643_ref5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1126\/science.abm6222","article-title":"Analysis of somatic mutations in 131 human brains reveals aging-associated hypermutability","volume":"377","author":"Bae","year":"2022","journal-title":"Science"},{"key":"10.3233\/JAD-220643_ref6","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1172\/JCI98199","article-title":"Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome","volume":"128","author":"Hacohen-Kleiman","year":"2018","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-220643_ref7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2021.09.018","article-title":"Novel ADNP syndrome mice reveal dramatic sex-specific peripheral gene expression with brain synaptic and tau pathologies","volume":"92","author":"Karmon","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-220643_ref8","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1038\/s41380-021-01143-9","article-title":"Introducing ADNP and SIRT1 as new partners regulating microtubules and histone methylation","volume":"26","author":"Hadar","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-220643_ref9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1471-4159.2007.05173.x","article-title":"Silencing of the ADNP-family member, ADNP2, results in changes in cellular viability under oxidative stress","volume":"105","author":"Kushnir","year":"2008","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-220643_ref10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41467-021-27722-6","article-title":"Proximity labeling identifies a repertoire of site-specific R-loop modulators","volume":"13","author":"Yan","year":"2022","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-220643_ref11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2006.03.029","article-title":"Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress","volume":"252","author":"Steingart","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.3233\/JAD-220643_ref12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s12031-021-01865-z","article-title":"Editorial: Designing a protocol adopting an Artificial Intelligence (AI)-driven approach for early diagnosis of late-onset Alzheimer\u2019s disease","volume":"71","author":"Li","year":"2021","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-220643_ref14","doi-asserted-by":"crossref","first-page":"e050559","DOI":"10.1002\/alz.050559","article-title":"Prevalence of mild behavioral impairment subdomains: A meta-analysis","volume":"17","author":"Pan","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220643_ref15","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3233\/JAD-201158","article-title":"Putative blood somatic mutations in post-traumatic stress disorder-symptomatic soldiers: High impact of cytoskeletal and inflammatory proteins","volume":"79","author":"Sragovich","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220643_ref16","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/S2666-7568(21)00140-9","article-title":"Mortality rates in Alzheimer\u2019s disease and non-Alzheimer\u2019s dementias: A systematic review and meta-analysis","volume":"2","author":"Liang","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.3233\/JAD-220643_ref17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/15622975.2017.1375556","article-title":"Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry","volume":"19","author":"Lewczuk","year":"2018","journal-title":"World J Biol Psychiatry"},{"key":"10.3233\/JAD-220643_ref18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220643_ref19","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-beta pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-220643_ref20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220643_ref21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13584-019-0290-z","article-title":"Dementia care in Israel: Top down and bottom up processes","volume":"8","author":"Bentur","year":"2019","journal-title":"Isr J Health Policy Res"},{"key":"10.3233\/JAD-220643_ref22","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-220643_ref23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s42003-019-0599-8","article-title":"3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice","volume":"2","author":"Gail Canter","year":"2019","journal-title":"Commun Biol"},{"key":"10.3233\/JAD-220643_ref24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220643_ref25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-019-02036-6","article-title":"Alzheimer\u2019s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation","volume":"138","author":"Petersen","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220643_ref26","first-page":"353","article-title":"Alzheimer\u2019s disease in Down Syndrome","volume":"1","author":"Head","year":"2012","journal-title":"Eur J Neurodegener Dis"},{"key":"10.3233\/JAD-220643_ref27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.17294\/2330-0698.1875","article-title":"Prevalence of mental health conditions among 6078 individuals with Down Syndrome in the United States","volume":"9","author":"Rivelli","year":"2022","journal-title":"J Patient Cent Res Rev"},{"key":"10.3233\/JAD-220643_ref28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/qjmed\/hcr118","article-title":"Non-psychiatric comorbidity associated with Alzheimer\u2019s disease","volume":"104","author":"Duthie","year":"2011","journal-title":"QJM"},{"key":"10.3233\/JAD-220643_ref29","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The infectious etiology of Alzheimer\u2019s disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-220643_ref30","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-170020","article-title":"Altered gut microbiota in a mouse model of Alzheimer\u2019s disease","volume":"60","author":"Zhang","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220643_ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer\u2019s disease","volume":"58","author":"Jiang","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220643_ref32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fcimb.2020.00104","article-title":"The links between the gut microbiome, aging, modern lifestyle and Alzheimer\u2019s disease","volume":"10","author":"Askarova","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.3233\/JAD-220643_ref33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12035-012-8281-x","article-title":"Alzheimer\u2019s disease, oestrogen and mitochondria: An ambiguous relationship","volume":"46","author":"Grimm","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-220643_ref34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13195-019-0551-7","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease","volume":"11","author":"van der Velpen","year":"2019","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220643_ref35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jfda.2018.11.009","article-title":"Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer\u2019s disease","volume":"27","author":"Yang","year":"2019","journal-title":"J Food Drug Anal"},{"key":"10.3233\/JAD-220643_ref36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuro.2013.07.010","article-title":"Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb)","volume":"39","author":"Bihaqi","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.3233\/JAD-220643_ref37","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.jalz.2014.04.009","article-title":"Smoking and increased Alzheimer\u2019s disease risk: A review of potential mechanisms","volume":"10","author":"Durazzo","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220643_ref38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnagi.2018.00042","article-title":"Lipopolysaccharide associates with Amyloid plaques, neurons and oligodendrocytes in Alzheimer\u2019s disease brain: A review","volume":"10","author":"Zhan","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220643_ref39","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.3390\/ijerph16245152","article-title":"A hypothesis and evidence that mercury may be an etiological factor in Alzheimer\u2019s disease","volume":"16","author":"Siblerud","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.3233\/JAD-220643_ref40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2015.19451","article-title":"Association of seafood consumption, brain mercury level, and APOE epsilon4 Status with brain neuropathology in older adults","volume":"315","author":"Morris","year":"2016","journal-title":"JAMA"},{"key":"10.3233\/JAD-220643_ref41","doi-asserted-by":"crossref","first-page":"102001","DOI":"10.1289\/EHP4579","article-title":"Environmental factors in successful aging: The potential impact of air pollution","volume":"127","author":"Schmidt","year":"2019","journal-title":"Environ Health Perspect"},{"key":"10.3233\/JAD-220643_ref42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12264-013-1425-9","article-title":"Environmental factors in the development and progression of late-onset Alzheimer\u2019s disease","volume":"30","author":"Wainaina","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.3233\/JAD-220643_ref43","doi-asserted-by":"crossref","first-page":"834661","DOI":"10.3389\/fcell.2022.834661","article-title":"Early-life environment influence on late-onset Alzheimer\u2019s disease","volume":"10","author":"Gauvrit","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.3233\/JAD-220643_ref44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1744-9081-2-13","article-title":"Variation at APOE and STH loci and Alzheimer\u2019s disease","volume":"2","author":"Zuo","year":"2006","journal-title":"Behav Brain Funct"},{"key":"10.3233\/JAD-220643_ref45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-4159.2011.07477.x","article-title":"Identification and biology of \u03b1-secretase","volume":"120","author":"Vingtdeux","year":"2012","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-220643_ref46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fnagi.2018.00118","article-title":"The physiological roles of Amyloid-\u03b2 peptide hint at new ways to treat Alzheimer\u2019s disease","volume":"10","author":"Brothers","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220643_ref47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fncel.2014.00427","article-title":"The \u03b3-secretase complex: From structure to function","volume":"8","author":"Zhang","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-220643_ref48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2353\/ajpath.2007.060378","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 regulate amyloid-\u03b2 plaque deposition and \u03b2-secretase expression in Swedish mutant APP transgenic mice","volume":"170","author":"Yamamoto","year":"2007","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-220643_ref49","doi-asserted-by":"crossref","first-page":"13389","DOI":"10.1074\/jbc.M111571200","article-title":"Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD)","volume":"277","author":"Edbauer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220643_ref50","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41598-020-80164-w","article-title":"The Abeta(1-38) peptide is a negative regulator of the Abeta(1-42) peptide implicated in Alzheimer disease progression","volume":"11","author":"Quartey","year":"2021","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-220643_ref51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40520-016-0539-0","article-title":"Relationship between the polymorphism in exon 5 of BACE1 gene and Alzheimer\u2019s disease","volume":"29","author":"Wang","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"10.3233\/JAD-220643_ref52","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00415-005-0799-7","article-title":"PEN\u20132 gene mutation in a familial Alzheimer\u2019s disease case","volume":"252","author":"Sala Frigerio","year":"2005","journal-title":"J Neurol"},{"key":"10.3233\/JAD-220643_ref53","doi-asserted-by":"crossref","first-page":"e17298","DOI":"10.1371\/journal.pone.0017298","article-title":"Deep sequencing of the nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer\u2019s disease","volume":"6","author":"Lupton","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220643_ref54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1113\/jphysiol.2006.111203","article-title":"Physiological roles for amyloid \u03b2 peptides","volume":"575","author":"Pearson","year":"2006","journal-title":"J Physiol"},{"key":"10.3233\/JAD-220643_ref55","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The Amyloid-\u03b2 oligomer hypothesis: Beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220643_ref56","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","article-title":"Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model","volume":"10","author":"Spangenberg","year":"2019","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-220643_ref57","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-220643_ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-008-8019-y","article-title":"The ART of loss: A\u03b2 imaging in the evaluation of Alzheimer\u2019s disease and other dementias","volume":"38","author":"Villemagne","year":"2008","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-220643_ref59","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/brain\/awz142","article-title":"Persistent neuropathological effects 14 years following amyloid-\u03b2 immunization in Alzheimer\u2019s disease","volume":"142","author":"Nicoll","year":"2019","journal-title":"Brain"},{"key":"10.3233\/JAD-220643_ref60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.3233\/JAD-220643_ref61","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","article-title":"A phase 3 trial of IV immunoglobulin for Alzheimer disease","volume":"88","author":"Relkin","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-220643_ref62","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamaneurol.2022.0315","article-title":"Cost-effectiveness of Aducanumab and Donanemab for early Alzheimer disease in the US","volume":"79","author":"Ross","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220643_ref63","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s43441-022-00390-4","article-title":"Application of meta-analysis to evaluate relationships among ARIA-E rate, amyloid reduction rate, and clinical cognitive response in amyloid therapeutic clinical trials for early Alzheimer\u2019s disease","volume":"56","author":"Wang","year":"2022","journal-title":"Ther Innov Regul Sci"},{"key":"10.3233\/JAD-220643_ref64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13024-021-00490-z","article-title":"Talking points for physicians, patients and caregivers consideringAduhelm\u00ae infusion and the accelerated pathway for its approval by the FDA","volume":"16","author":"Gandy","year":"2021","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-220643_ref65","doi-asserted-by":"crossref","first-page":"84","DOI":"10.15212\/bioi-2021-0034","article-title":"Hope or hype? Aducanumab as a magic bullet for Alzheimer\u2019s disease","volume":"3","author":"Lin","year":"2022","journal-title":"BIOI"},{"key":"10.3233\/JAD-220643_ref66","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1172\/JCI66827","article-title":"Fc\u03b3RIIb mediates amyloid-\u03b2 neurotoxicity and memory impairment in Alzheimer\u2019s disease","volume":"123","author":"Kam","year":"2013","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-220643_ref67","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J"},{"key":"10.3233\/JAD-220643_ref68","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1405803111","article-title":"Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer\u2019s disease","volume":"111","author":"Fu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220643_ref69","doi-asserted-by":"crossref","first-page":"17112","DOI":"10.1074\/jbc.M116.720664","article-title":"Oligomers of amyloid \u03b2 prevent physiological activation of the cellular prion protein-metabotropic glutamate receptor 5 complex by glutamate in Alzheimer disease","volume":"291","author":"Haas","year":"2016","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220643_ref70","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1126\/science.ade0350","article-title":"Research backing experimental Alzheimer\u2019s drug was first target of suspicion","volume":"377","author":"Piller","year":"2022","journal-title":"Science"},{"key":"10.3233\/JAD-220643_ref71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","article-title":"Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease","volume":"6","author":"Neddens","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-220643_ref72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brainres.2011.03.052","article-title":"Association analysis of GSK3B and MAPT polymorphisms with Alzheimer\u2019s disease in Han Chinese","volume":"1391","author":"Zhang","year":"2011","journal-title":"Brain Res"},{"key":"10.3233\/JAD-220643_ref73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/alzrt268","article-title":"Association of MAPT haplotypes with Alzheimer\u2019s disease risk and MAPT brain gene expression levels","volume":"6","author":"Allen","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220643_ref74","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1873-3468.13108","article-title":"Tau filaments in neurodegenerative diseases","volume":"592","author":"Goedert","year":"2018","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-220643_ref75","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/01.wad.0000183082.76820.81","article-title":"Tau alternative splicing and frontotemporal dementia","volume":"19","author":"Kar","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-220643_ref76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fneur.2013.00083","article-title":"The importance of tau phosphorylation for neurodegenerative diseases","volume":"4","author":"Noble","year":"2013","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-220643_ref77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1523\/JNEUROSCI.2305-16.2016","article-title":"Tau isoforms imbalance impairs the axonal transport of the amyloid precursor protein in human neurons","volume":"37","author":"Lacovich","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220643_ref78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2017.05.003","article-title":"Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy","volume":"105","author":"Sealey","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-220643_ref79","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3233\/JAD-2010-100975","article-title":"Alzheimer\u2019s disease: A general introduction and pathomechanism","volume":"22","author":"Finder","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220643_ref80","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1523\/JNEUROSCI.2842-14.2015","article-title":"Tau phosphorylation at serine 396 residue is required for hippocampal LTD","volume":"35","author":"Regan","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220643_ref81","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.neurobiolaging.2014.05.005","article-title":"Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion","volume":"35","author":"Ahmed","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220643_ref82","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220643_ref83","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","article-title":"Amyloid-\u03b2\/Fyn\u2013induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220643_ref84","doi-asserted-by":"crossref","first-page":"e21807","DOI":"10.1096\/fj.202100718R","article-title":"Pneumonia initiates a tauopathy","volume":"35","author":"Balczon","year":"2021","journal-title":"FASEB J"},{"key":"10.3233\/JAD-220643_ref85","doi-asserted-by":"crossref","first-page":"e0153724","DOI":"10.1371\/journal.pone.0153724","article-title":"Humanized tau mice with regionalized amyloid exhibit behavioral deficits but no pathological interaction","volume":"11","author":"Yetman","year":"2016","journal-title":"Plos One"},{"key":"10.3233\/JAD-220643_ref86","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00401-001-0477-5","article-title":"Neuron loss from the hippocampus of Alzheimer\u2019s disease exceeds extracellular neurofibrillary tangle formation","volume":"103","author":"Kril","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220643_ref87","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220643_ref88","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00401-021-02294-3","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease with PET ligand APN-1607","volume":"141","author":"Shi","year":"2021","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220643_ref89","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.sbi.2020.05.011","article-title":"Cryo-EM structures of tau filaments","volume":"64","author":"Scheres","year":"2020","journal-title":"Curr Opin Struct Biol"},{"key":"10.3233\/JAD-220643_ref90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnins.2018.00044","article-title":"Phospho-Tau Bar Code: Analysis of phosphoisotypes of tau and its application to tauopathy","volume":"12","author":"Kimura","year":"2018","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-220643_ref91","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenarative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-220643_ref92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3940(00)00972-1","article-title":"Tau polymorphisms are not associated with Alzheimer\u2019s disease","volume":"284","author":"Kwon","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220643_ref93","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00001756-200401190-00034","article-title":"Association between tau polymorphism and male early-onset Alzheimer\u2019s disease","volume":"15","author":"Tanahashi","year":"2004","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-220643_ref94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(02)00190-8","article-title":"A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer\u2019s disease, nor does it influence the extent of tau pathology in the brain","volume":"324","author":"Green","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220643_ref95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ageing\/afq131","article-title":"Genetic evidence that vascular dementia is related to Alzheimer\u2019s disease: Genetic association between tau polymorphism and vascular dementia in the Chinese population","volume":"40","author":"Ning","year":"2011","journal-title":"Age Ageing"},{"key":"10.3233\/JAD-220643_ref96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-021-02392-2","article-title":"Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD","volume":"143","author":"Bowles","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220643_ref97","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/biom6010006","article-title":"Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies","volume":"6","author":"Simi\u0107","year":"2016","journal-title":"Biomolecules"},{"key":"10.3233\/JAD-220643_ref98","doi-asserted-by":"crossref","first-page":"hzu002","DOI":"10.1093\/biohorizons\/hzu002","article-title":"An effective treatment for Alzheimer\u2019s disease must consider both amyloid and tau","volume":"7","author":"Lansdall","year":"2014","journal-title":"Biosci Horiz"},{"key":"10.3233\/JAD-220643_ref99","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JAD-220643_ref100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/hmg\/ddn326","article-title":"Dissociation of tau toxicity and phosphorylation: Role of GSK-3\u03b2, MARK and Cdk5 in a Drosophila model","volume":"18","author":"Chatterjee","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-220643_ref101","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuron.2012.06.026","article-title":"Tau promotesneurodegeneration via DRP1 mislocalization in vivo.","volume":"75","author":"DuBoff","year":"2012","journal-title":"Neuron"},{"key":"10.3233\/JAD-220643_ref102","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-220643_ref103","doi-asserted-by":"crossref","first-page":"15295","DOI":"10.1038\/ncomms15295","article-title":"Tau association with synaptic vesicles causes presynaptic dysfunction","volume":"8","author":"Zhou","year":"2017","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-220643_ref104","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13041-017-0298-7","article-title":"Propagation of Tau aggregates","volume":"10","author":"Goedert","year":"2017","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-220643_ref105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12031-017-0983-0","article-title":"Tau diagnostics and clinical studies","volume":"63","author":"Gozes","year":"2017","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-220643_ref106","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.15252\/emmm.202114022","article-title":"Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau","volume":"13","author":"Mattsson-Carlgren","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-220643_ref107","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220643_ref108","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease","volume":"11","author":"Vogel","year":"2020","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-220643_ref109","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/19336896.2016.1223003","article-title":"Tunneling nanotubes: A possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases","volume":"10","author":"Abounit","year":"2016","journal-title":"Prion"},{"key":"10.3233\/JAD-220643_ref110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41398-018-0150-6","article-title":"GWAS on family history of Alzheimer\u2019s disease","volume":"8","author":"Marioni","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-220643_ref111","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-220643_ref112","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.3233\/JAD-220643_ref113","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2009-04-211417","article-title":"Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells","volume":"114","author":"Allan","year":"2009","journal-title":"Blood"},{"key":"10.3233\/JAD-220643_ref114","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9440(10)65305-9","article-title":"Specific regional transcription of apolipoprotein E in human brain neurons","volume":"154","author":"Xu","year":"1999","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-220643_ref115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2202-11-23","article-title":"Apolipoprotein-E forms dimers in human frontal cortex and hippocampus","volume":"11","author":"Elliott","year":"2010","journal-title":"BMC Neurosci"},{"key":"10.3233\/JAD-220643_ref116","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.3233\/JAD-220643_ref117","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/iub.1314","article-title":"Apolipoprotein E isoforms and lipoprotein metabolism","volume":"66","author":"Phillips","year":"2014","journal-title":"IUBMB Life"},{"key":"10.3233\/JAD-220643_ref118","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): Questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-220643_ref119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1385\/JMN:23:3:149","article-title":"Apolipoprotein E knockout mice as a model of behavioral dysfunction","volume":"23","author":"Gozes","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-220643_ref120","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220643_ref121","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"10.3233\/JAD-220643_ref122","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.3233\/JAD-220643_ref123","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12031-019-01397-7","article-title":"ApoE4 exacerbates hippocampal pathology following acute brain penetration injury in female mice","volume":"70","author":"Ben-Moshe","year":"2020","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-220643_ref124","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.3233\/JAD-220643_ref125","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220643_ref126","doi-asserted-by":"crossref","first-page":"10571","DOI":"10.1021\/bi9626362","article-title":"Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide \u03b2 (1\u201340). Relevance to Alzheimer\u2019s disease","volume":"36","author":"Aleshkov","year":"1997","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-220643_ref127","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1021\/bi0017475","article-title":"SDS-stable complex formation between native apolipoprotein E3 and \u03b2-amyloid peptides","volume":"39","author":"Munson","year":"2000","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-220643_ref128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","article-title":"TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy","volume":"12","author":"Bemiller","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-220643_ref129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/WCO.0000000000000911","article-title":"The role of innate immune genes in Alzheimer\u2019s disease","volume":"34","author":"Griciuc","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"10.3233\/JAD-220643_ref130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(02)00780-2","article-title":"An association study of a functional catalase gene polymorphism, -262C\u2013>T, and patients with Alzheimer\u2019s disease","volume":"330","author":"Goulas","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220643_ref131","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10072-015-2245-7","article-title":"Glutathione S-transferases variants as risk factors in Alzheimer\u2019s disease","volume":"36","author":"Wang","year":"2015","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-220643_ref132","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neulet.2017.12.026","article-title":"Association of GPX1 and GPX4 polymorphisms with episodic memory and Alzheimer\u2019s disease","volume":"666","author":"da Rocha","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220643_ref133","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1601-183X.2007.00308.x","article-title":"A polymorphism in SOD2 is associated with development of Alzheimer\u2019s disease","volume":"6","author":"Wiener","year":"2007","journal-title":"Genes Brain Behav"},{"key":"10.3233\/JAD-220643_ref134","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pjnns.2014.09.002","article-title":"rs2070424 of the SOD1 gene is associated with risk of Alzheimer\u2019s disease","volume":"48","author":"Spisak","year":"2014","journal-title":"Neurol Neurochir Pol"},{"key":"10.3233\/JAD-220643_ref135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7555\/JBR.30.20150131","article-title":"Autoantibodies in Alzheimer\u2019s disease: Potential biomarkers, pathogenic roles, and therapeutic implications","volume":"30","author":"Wu","year":"2016","journal-title":"J Biomed Res"},{"key":"10.3233\/JAD-220643_ref136","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10571-015-0233-3","article-title":"Role of RAGE in Alzheimer\u2019s disease","volume":"36","author":"Cai","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-220643_ref137","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00702-010-0437-0","article-title":"Association of the RAGE G82S polymorphism with Alzheimer\u2019s disease","volume":"117","author":"Daborg","year":"2010","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-220643_ref138","doi-asserted-by":"crossref","first-page":"e0222921","DOI":"10.1371\/journal.pone.0222921","article-title":"Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer\u2019s patients","volume":"14","author":"Potashkin","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220643_ref139","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2020.06.028","article-title":"Transcription factor NRF2 as a promising therapeutic target for Alzheimer\u2019s disease","volume":"159","author":"Qu","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-220643_ref140","doi-asserted-by":"crossref","first-page":"785057","DOI":"10.3389\/fncel.2021.785057","article-title":"Nuclear factor erythroid-2-related factor 2 signaling in the neuropathophysiology of inherited metabolic disorders","volume":"15","author":"Seminotti","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-220643_ref141","doi-asserted-by":"crossref","first-page":"12516","DOI":"10.1073\/pnas.1819541116","article-title":"NRF2\/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer\u2019s models","volume":"116","author":"Bahn","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220643_ref142","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1038\/s41380-020-00956-4","article-title":"C\/EBPbeta is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer\u2019s disease","volume":"26","author":"Xia","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-220643_ref143","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1471-4159.1999.0721283.x","article-title":"Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide","volume":"72","author":"Bassan","year":"1999","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-220643_ref144","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1038\/tp.2014.138","article-title":"Activity-Dependent Neuroprotective Protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer\u2019s pathologies","volume":"5","author":"Malishkevich","year":"2015","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-220643_ref145","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ydbio.2006.11.039","article-title":"Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis","volume":"303","author":"Mandel","year":"2007","journal-title":"Dev Biol"},{"key":"10.3233\/JAD-220643_ref146","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1074\/jbc.M007416200","article-title":"Cloning and characterization of the human activity-dependent neuroprotective protein","volume":"276","author":"Zamostiano","year":"2001","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220643_ref147","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.107.129551","article-title":"Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model","volume":"323","author":"Vulih-Shultzman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-220643_ref148","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/mp.2015.208","article-title":"Sexual divergence in microtubule function: The novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory","volume":"21","author":"Amram","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-220643_ref149","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1016\/j.jprot.2012.04.017","article-title":"Activity-dependent neuroprotector homeobox protein: A candidaterotein identified in serum as diagnostic biomarker for Alzheimer\u2019s disease","volume":"75","author":"Yang","year":"2012","journal-title":"J Proteomics"},{"key":"10.3233\/JAD-220643_ref150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3233\/JAD-150799","article-title":"Blood-borne Activity-Dependent Neuroprotective Protein (ADNP) is correlated with premorbid intelligence, clinical stage, and Alzheimer\u2019s disease biomarkers","volume":"50","author":"Malishkevich","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220643_ref151","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/mp.2016.255","article-title":"ADNP\/NAP dramatically increase microtubule end-binding protein-Tau interaction: A novel avenue for protection against tauopathy","volume":"22","author":"Ivashko-Pachima","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-220643_ref152","doi-asserted-by":"crossref","first-page":"e0213666","DOI":"10.1371\/journal.pone.0213666","article-title":"NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies","volume":"14","author":"Ivashko-Pachima","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220643_ref153","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.bbamem.2013.09.016","article-title":"Reactive oxygen species at phospholipid bilayers: Distribution, mobility and permeation","volume":"1838","author":"Cordeiro","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-220643_ref154","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1203\/PDR.0b013e3181a9eafb","article-title":"Oxygen toxicity and reactive oxygen species: The devil is in the details","volume":"66","author":"Auten","year":"2009","journal-title":"Pediatr Res"},{"key":"10.3233\/JAD-220643_ref155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/nbdi.1999.0273","article-title":"Oxidative insults are associated with apolipoprotein E genotype in Alzheimer\u2019s disease brain","volume":"7","author":"Ramassamy","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-220643_ref156","doi-asserted-by":"crossref","first-page":"6435861","DOI":"10.1155\/2018\/6435861","article-title":"Oxidant\/antioxidant imbalance in Alzheimer\u2019s disease: Therapeutic and diagnostic prospects","volume":"2018","author":"Wojsiat","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.3233\/JAD-220643_ref157","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tins.2004.07.005","article-title":"Free radicals and aging","volume":"27","author":"Barja","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-220643_ref158","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12877-019-1109-z","article-title":"Associations between superoxide dismutase, malondialdehyde and all-cause mortality in older adults: A community-based cohort study","volume":"19","author":"Mao","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.3233\/JAD-220643_ref159","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4161\/derm.21819","article-title":"The role of manganese superoxide dismutase in skin aging","volume":"4","author":"Treiber","year":"2012","journal-title":"Dermatoendocrinol"},{"key":"10.3233\/JAD-220643_ref160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3233\/JAD-190863","article-title":"Molecular mechanisms and genetics of oxidative stress in Alzheimer\u2019s disease","volume":"72","author":"Cioffi","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220643_ref161","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11064-007-9453-3","article-title":"Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias","volume":"33","author":"Casado","year":"2008","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-220643_ref162","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adh Migr"},{"key":"10.3233\/JAD-220643_ref163","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220643_ref164","doi-asserted-by":"crossref","first-page":"14244","DOI":"10.1038\/s41598-019-50837-2","article-title":"New screening approach for Alzheimer\u2019s disease risk assessment from urine lipid peroxidation compounds","volume":"9","author":"Pe\u00f1a-Bautista","year":"2019","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-220643_ref165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/cclm.2011.792","article-title":"Urinary 8-hydroxy-2\u2032-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer\u2019s disease","volume":"50","author":"Zengi","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"10.3233\/JAD-220643_ref166","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2217\/bmm-2017-0388","article-title":"A review of biomarkers of Alzheimer\u2019s disease in noninvasive samples","volume":"12","author":"Hartmann","year":"2018","journal-title":"Biomark Med"},{"key":"10.3233\/JAD-220643_ref167","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10590500902885684","article-title":"8-hydroxy-2-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"key":"10.3233\/JAD-220643_ref168","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41586-022-04640-1","article-title":"Somatic genomic changes in single Alzheimer\u2019s disease neurons","volume":"604","author":"Miller","year":"2022","journal-title":"Nature"},{"key":"10.3233\/JAD-220643_ref169","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ajmg.b.32429","article-title":"Adult neurogenesis and neurodegenerative diseases: A systems biology perspective","volume":"174","author":"Horgusluoglu","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.3233\/JAD-220643_ref170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41591-019-0375-9","article-title":"Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer\u2019s disease","volume":"25","author":"Moreno-Jimenez","year":"2019","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220643_ref171","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mad.2016.03.007","article-title":"Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain","volume":"161","author":"Andriani","year":"2017","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-220643_ref172","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-022-04912-w","article-title":"Molecular landscapes of human hippocampal immatureneurons across lifespan","volume":"607","author":"Zhou","year":"2022","journal-title":"Nature"},{"key":"10.3233\/JAD-220643_ref173","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41398-020-00904-4","article-title":"Tauopathy in the young autistic brain: Novel biomarker and theraeutic target","volume":"10","author":"Grigg","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-220643_ref174","doi-asserted-by":"crossref","first-page":"867442","DOI":"10.3389\/fendo.2022.867442","article-title":"STOP codon mutations at sites of natural caspase cleavage are implicated in Autism and Alzheimer\u2019s disease: The Case of ADNP","volume":"13","author":"Gozes","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.3233\/JAD-220643_ref175","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-018-1850-y","article-title":"Somatic mutations in neurons during aging and neurodegeneration","volume":"135","author":"Verheijen","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220643_ref176","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/nan.12465","article-title":"Review: Somatic mutations in neurodegeneration","volume":"44","author":"Leija-Salazar","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-220643_ref177","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/dneu.22626","article-title":"Genomic mosaicism in the developing and adult brain","volume":"78","author":"Rohrback","year":"2018","journal-title":"Dev Neurobiol"},{"key":"10.3233\/JAD-220643_ref178","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01568-w"},{"key":"10.3233\/JAD-220643_ref179","doi-asserted-by":"crossref","first-page":"e5465","DOI":"10.1371\/journal.pone.0005465","article-title":"Apolipoprotein C3 polymorphisms, cognitive function and diabetes in Caribbean origin Hispanics","volume":"4","author":"Smith","year":"2009","journal-title":"Plos One"},{"key":"10.3233\/JAD-220643_ref180","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2174\/1381612822666151209152013","article-title":"Alterations in glucose metabolism on cognition: A possible link between diabetes and dementia","volume":"22","author":"Gonz\u00e1lez-Reyes","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-220643_ref181","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000118898","article-title":"Therapeutic efficacy of pyritinol in patients with Senile Dementia of the Alzheimer type (SDAT) and Multi-Infarct Dementia (MID)","volume":"26","author":"Fischhof","year":"1992","journal-title":"Neuropsychobiology"},{"key":"10.3233\/JAD-220643_ref182","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13229-016-0103-y","article-title":"A systematic variant annotation approach for ranking genes associated with Autism spectrum disorders","volume":"7","author":"Larsen","year":"2016","journal-title":"Mol Autism"},{"key":"10.3233\/JAD-220643_ref183","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biopsych.2021.04.013","article-title":"A different outlook at psychiatric and neurological diseases: Brain somatic mutations are implicated in schizophrenia","volume":"90","author":"Gozes","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-220643_ref184","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01603-w"},{"key":"10.3233\/JAD-220643_ref185","doi-asserted-by":"crossref","unstructured":"(2017) 2017 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 13, 325\u2013373.","DOI":"10.1016\/j.jalz.2017.02.001"},{"key":"10.3233\/JAD-220643_ref186","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2019.05.031","article-title":"Sex differences in Alzheimer\u2019s disease: Understanding the molecular impact","volume":"1719","author":"Toro","year":"2019","journal-title":"Brain Res"},{"key":"10.3233\/JAD-220643_ref187","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trci.2015.07.001","article-title":"Marked gender differences in progression of mild cognitive impairment over 8 years","volume":"1","author":"Lin","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220643_ref188","doi-asserted-by":"crossref","unstructured":"(2022) 2022 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 18, 700\u2013789.","DOI":"10.1002\/alz.12638"},{"key":"10.3233\/JAD-220643_ref189","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JAD-220643_ref190","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamaneurol.2020.0117","article-title":"Association of stress-related disorders with subsequent neurodegenerative diseases","volume":"77","author":"Song","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220643_ref191","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1192\/bjp.2020.150","article-title":"Post-traumatic stress disorder as a risk factor for dementia: Systematic review and meta-analysis","volume":"217","author":"Gunak","year":"2020","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-220643_ref192","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/archgenpsychiatry.2010.61","article-title":"Posttraumatic stress disorder and risk of dementia among US veterans","volume":"67","author":"Yaffe","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-220643_ref193","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1017\/S1355617709990282","article-title":"Longitudinal effects of PTSD on memory functioning","volume":"15","author":"Samuelson","year":"2009","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-220643_ref194","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archgenpsychiatry.2009.205","article-title":"Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder","volume":"67","author":"Wang","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-220643_ref195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pscychresns.2007.04.011","article-title":"Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder","volume":"162","author":"Schuff","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.3233\/JAD-220643_ref196","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archgenpsychiatry.2009.160","article-title":"Smaller global and regional cortical volume in combat-related posttraumatic stress disorder","volume":"66","author":"Woodward","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-220643_ref197","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1176\/appi.ajp.161.8.1390","article-title":"Posttraumatic stress disorder and depression following trauma: Understanding comorbidity","volume":"161","author":"O\u2019Donnell","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-220643_ref198","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1176\/ajp.155.5.630","article-title":"Prospective study of posttraumatic stress disorder and depression following trauma","volume":"155","author":"Shalev","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-220643_ref199","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jagp.2019.08.006","article-title":"The interplay between post-traumatic stress disorder and dementia: A systematic review","volume":"28","author":"Desmarais","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-220643_ref200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapsychiatry.2021.0109","article-title":"Posttraumatic stress disorder in patients after severe COVID-19 infection","volume":"78","author":"Janiri","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.3233\/JAD-220643_ref201","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41398-019-0569-4","article-title":"The Autism-mutated ADNP plays a key role in stress response","volume":"9","author":"Sragovich","year":"2019","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-220643_ref202","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01704-6"},{"key":"10.3233\/JAD-220643_ref203","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00415-003-0999-y","article-title":"Epidemiology of dementia in Ashkelon","volume":"250","author":"Kahana","year":"2003","journal-title":"J Neurol"},{"key":"10.3233\/JAD-220643_ref204","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/jhg.2013.114","article-title":"The promise of whole-exome sequencing in medical genetics","volume":"59","author":"Rabbani","year":"2014","journal-title":"J Hum Genet"},{"key":"10.3233\/JAD-220643_ref205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mehy.2018.03.008","article-title":"The role of Alu-derived RNAs in Alzheimer\u2019s and other neurodegenerative conditions","volume":"115","author":"Polesskaya","year":"2018","journal-title":"Med Hypotheses"},{"key":"10.3233\/JAD-220643_ref206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10577-018-9573-4","article-title":"Warning SINEs: Alu elements, evolution of the human brain, and the of neurological spectrum disease","volume":"26","author":"Larsen","year":"2018","journal-title":"Chromosome Res"},{"key":"10.3233\/JAD-220643_ref207","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2018.10.017","article-title":"Translating Alzheimer\u2019s disease-associated polymorphisms into functional candidates: A survey of IGAP genes and SNPs","volume":"74","author":"Katsumata","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220643_ref208","doi-asserted-by":"crossref","first-page":"16481","DOI":"10.1073\/pnas.0902833106","article-title":"Dendritic trafficking of BDNF mRNA is mediated by translin and blocked by the G196A (Val66Met) mutation","volume":"106","author":"Chiaruttini","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220643_ref209","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-021-03477-4","article-title":"Somatic mutation landscapes at single-molecule resolution","volume":"593","author":"Abascal","year":"2021","journal-title":"Nature"},{"key":"10.3233\/JAD-220643_ref210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-018-0718-6","article-title":"Somatic APP gene recombination in Alzheimer\u2019s disease and normal neurons","volume":"563","author":"Lee","year":"2018","journal-title":"Nature"},{"key":"10.3233\/JAD-220643_ref211","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1038\/s41586-020-2522-3","article-title":"APP gene copy number changes reflect exogenous contamination","volume":"584","author":"Kim","year":"2020","journal-title":"Nature"},{"key":"10.3233\/JAD-220643_ref212","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neurobiolaging.2021.07.010","article-title":"Absence of coding somatic single nucleotide variants within well-known candidate genes in late-onset sporadic Alzheimer\u2019s Disease based on the analysis of multi-omics data","volume":"108","author":"Min","year":"2021","journal-title":"Neurobiol Aging"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:38Z","timestamp":1777370858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":211,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-220643","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]}}}